Deciphera Pharmaceuticals’ $172.5 Million Stock and Pre-Funded Warrants Offering

Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering.Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and pre-funded…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now